Battery Life of Pulse Generators in Spinal Cord Stimulation: Analysis and Comparison Between Surgical and Percutaneous Leads in Energy Efficiency
Metadatos
Mostrar el registro completo del ítemAutor
Gómez González, Marta Antonia; Cordero Tous, Nicolás; Sánchez Corral, Carlos; Lechuga Carrasco, Beatriz; Sánchez-García, Manuel Alejandro; Gálvez Mateos, Rafael; Olivares Granados, GonzaloEditorial
MDPI
Materia
Spinal cord stimulation pulse generator failed back syndrome
Fecha
2025-09-21Referencia bibliográfica
Gómez González, M.A.; Cordero Tous, N.; Sánchez Corral, C.; Lechuga Carrasco, B.; Sánchez García, M.A.; Gálvez Mateos, R.; Olivares Granados, G. Battery Life of Pulse Generators in Spinal Cord Stimulation: Analysis and Comparison Between Surgical and Percutaneous Leads in Energy Efficiency. J. Clin. Med. 2025, 14, 6646. https://doi.org/10.3390/jcm14186646
Resumen
Background: Spinal cord stimulation (SCS) is an established therapy for chronic neuropathic pain. Although rechargeable and non-rechargeable pulse generators (PGs) are
widely used, their real-world battery life and the influence of lead type on energy efficiency
remain underexplored. Objective: To evaluate PG battery longevity and compare the performance of surgical versus percutaneous leads in terms of energy efficiency. Methods: We
conducted a retrospective study of 283 PGs implanted at Hospital Virgen de las Nieves
(Granada, Spain) from 1996 to 2023. Data on patient demographics, pain etiology, lead type
and placement, stimulation modality, and PG status were extracted. A competing risks
analysis was used to assess PG shutdown and early explantation over time. Results: Of the
PGs analyzed, 43.5% were non-rechargeable and 56.5% rechargeable. Rechargeable PGs
showed significantly longer battery life (mean: 82.7 vs. 38.9 months, p < 0.05), with a lower
probability of shutdown at 50, 100, and 150 months. No significant differences in battery
longevity were observed regarding lead location, stimulation type, or pain etiology. A trend
toward longer battery life was observed with percutaneous leads, although not statistically
significant. Conclusions: Rechargeable PGs demonstrated superior longevity compared
to non-rechargeable models and should be considered the preferred option in most cases.
While both surgical and percutaneous leads are effective, percutaneous systems may offer
improved battery efficiency. Further prospective studies are warranted to confirm these
findings and assess cost-effectiveness.





